Epithalon

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEpithalon
Drug Alias NameEpitalonBDM-EEpitalon - BioDiem
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiodem
China Registration ClassN/A

Develop Information

Active CompaniesBiodem
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A